[Anti-aldosterone: the evidence of the RALES study].
Zannad
F
F
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D015415:Biomarkers / Q000032:analysis; D002303:Cardiac Output, Low / Q000188:drug therapy*; D004232:Diuretics / Q000008:administration & dosage / Q000627:therapeutic use*; D004719:Endomyocardial Fibrosis / Q000517:prevention & control; D006760:Hospitalization; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D011347:Procollagen / Q000032:analysis; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013148:Spironolactone / Q000008:administration & dosage / Q000627:therapeutic use; D015996:Survival Rate
D000806:Angiotensin-Converting Enzyme Inhibitors; D015415:Biomarkers; D004232:Diuretics; D000451:Mineralocorticoid Receptor Antagonists; D011347:Procollagen; D013148:Spironolactone